Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2005

Open Access 01-12-2005 | Research

Lack of association between Chlamydia Pneumoniae serology and endothelial dysfunction of coronary arteries

Authors: Markus Ferrari, Gerald S Werner, Barbara M Richartz, Albrecht Oehme, Eberhard Straube, Hans R Figulla

Published in: Cardiovascular Ultrasound | Issue 1/2005

Login to get access

Abstract

Background

Recent publications brought up the hypothesis that an infection with Chlamydia Pneumoniae (CP) might be a major cause of coronary artery disease (CAD). Therefore, we investigated whether endothelial dysfunction (ED) as a precursor of atherosclerosis might be detectable in patients with previous infection with CP but without angiographic evidence of CAD.

Methods

We included 16 patients (6 male / 10 female) of 52 consecutive patients with normal coronary angiography who had typical angina pectoris and pathologic findings in the stress test. Exclusion criteria were: active smoker, elevated cholesterol, hypertension, age > 65 years, diabetes mellitus, treatment with ACE-inhibitors, or known CAD. Blood sample analysis for serum titer against CP (aCP-IgG) was performed after coronary angiography. We looked for endothelial dysfunction analyzing the diameter of the left anterior descending coronary artery (LAD) before and after acetylcholine (ACh) i. c. Quantitative analysis of luminal diameter (LD) was performed in at least two planes during baseline conditions and after ACh for 2 minutes in dosages of 7.2 μg/min and 36 μg/min with an infusion speed of 2 ml/min. Using Doppler guide wire, the coronary flow velocity was measured continuously in the LAD. The coronary flow velocity reserve (CFVR) was measured after 20 μg adenosine i. c.

Results

10 patients had an elevated aCP-IgG (> 1:8). 6 patients with negative titers (aCP-IgG ≤ 1:8) served as control (CTRL). Both groups were comparable in age, gender, angina class, results of non-invasive stress-test and the baseline values of LD and flow. In the CP positive group 3 patients (30%) did not show an increase of LD after ACh as evidence of ED. In the CTRL group 4 patients (67 %) had ED. There was no association between aCP-IgG and changes of coronary blood flow after ACh. All patients showed normal CFVR (3.0 ± 0.27) irrespective of their aCP-IgG values.

Conclusion

In patients with typical symptoms of coronary ischemia but without angiographically visible CAD and absence of other factors affecting the endothelial function, a previous infection with CP is not associated with endothelial dysfunction.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cannon RO 3rd, Quyyumi AA, Mincemoyer R, Stine AM, Gracely RH, Smith WB, Geraci MF, Black BC, Uhde TW, Waclawiw MA, Maher K, Benjamin SB: Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994, 330: 1411-1417. 10.1056/NEJM199405193302003PubMed Cannon RO 3rd, Quyyumi AA, Mincemoyer R, Stine AM, Gracely RH, Smith WB, Geraci MF, Black BC, Uhde TW, Waclawiw MA, Maher K, Benjamin SB: Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994, 330: 1411-1417. 10.1056/NEJM199405193302003PubMed
2.
go back to reference Mehta JL, Saldeen TG, Rand K: Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998, 31: 1217-1225. 10.1016/S0735-1097(98)00093-XPubMed Mehta JL, Saldeen TG, Rand K: Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998, 31: 1217-1225. 10.1016/S0735-1097(98)00093-XPubMed
3.
go back to reference Noll G: Pathogenesis of atherosclerosis: a possible relation to infection. Atherosclerosis 1998,140(Suppl):3-9. 10.1016/S0021-9150(98)00113-0 Noll G: Pathogenesis of atherosclerosis: a possible relation to infection. Atherosclerosis 1998,140(Suppl):3-9. 10.1016/S0021-9150(98)00113-0
4.
go back to reference Persson K: Epidemiological and clinical aspects on infections due to Chlamydia pneumoniae (strain TWAR). Scand J Infect Dis Suppl 1990, 69: 63-67.PubMed Persson K: Epidemiological and clinical aspects on infections due to Chlamydia pneumoniae (strain TWAR). Scand J Infect Dis Suppl 1990, 69: 63-67.PubMed
5.
go back to reference Juvonen J, Laurila A, Juvonen T, Alakarppa H, Surcel HM, Lounatmaa K, Kuusisto J, Saikku P: Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1997, 29: 1054-1059. 10.1016/S0735-1097(97)00003-XPubMed Juvonen J, Laurila A, Juvonen T, Alakarppa H, Surcel HM, Lounatmaa K, Kuusisto J, Saikku P: Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1997, 29: 1054-1059. 10.1016/S0735-1097(97)00003-XPubMed
6.
go back to reference Thomas M, Wong Y, Thomas D, Ajaz M, Tsang V, Gallagher PJ, Ward ME: Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation 1999, 99: 2733-2736.PubMed Thomas M, Wong Y, Thomas D, Ajaz M, Tsang V, Gallagher PJ, Ward ME: Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation 1999, 99: 2733-2736.PubMed
7.
go back to reference Hayashida K, Tanaka M, Morita H, Hayashi F, Inada T, Suzuki H, Sakamoto T, Katsuragawa M, Hibino H, Kambara H: Chlamydia pneumoniae seropositivity predicts the risk of restenosis after percutaneous transluminal coronary angioplasty. Heart Vessels 2002, 16: 137-145. 10.1007/s003800200010PubMed Hayashida K, Tanaka M, Morita H, Hayashi F, Inada T, Suzuki H, Sakamoto T, Katsuragawa M, Hibino H, Kambara H: Chlamydia pneumoniae seropositivity predicts the risk of restenosis after percutaneous transluminal coronary angioplasty. Heart Vessels 2002, 16: 137-145. 10.1007/s003800200010PubMed
8.
go back to reference Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ: Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997, 96: 404-407.PubMed Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ: Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997, 96: 404-407.PubMed
9.
go back to reference Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B: Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet 1997, 350: 404-407. 10.1016/S0140-6736(97)07201-2PubMed Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B: Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet 1997, 350: 404-407. 10.1016/S0140-6736(97)07201-2PubMed
10.
go back to reference Kontula K, Vuorio A, Turtola H, Saikku P: Association of seropositivity for Chlamydia pneumoniae and coronary artery disease in heterozygous familial hypercholesterolaemia. Lancet 1999, 354: 46-47. 10.1016/S0140-6736(99)01691-8PubMed Kontula K, Vuorio A, Turtola H, Saikku P: Association of seropositivity for Chlamydia pneumoniae and coronary artery disease in heterozygous familial hypercholesterolaemia. Lancet 1999, 354: 46-47. 10.1016/S0140-6736(99)01691-8PubMed
11.
go back to reference Hu H, Pierce GN, Zhong G: The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 1999, 103: 747-753.PubMedPubMedCentral Hu H, Pierce GN, Zhong G: The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 1999, 103: 747-753.PubMedPubMedCentral
12.
go back to reference Bhakdi S, Dorweiler B, Kirchmann R, Torzewski J, Weise E, Tranum-Jensen J, Walev I, Wieland E: On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J Exp Med 1995, 182: 1959-1971. 10.1084/jem.182.6.1959PubMed Bhakdi S, Dorweiler B, Kirchmann R, Torzewski J, Weise E, Tranum-Jensen J, Walev I, Wieland E: On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J Exp Med 1995, 182: 1959-1971. 10.1084/jem.182.6.1959PubMed
13.
go back to reference Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD: Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res 1988, 63: 903-910.PubMed Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD: Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res 1988, 63: 903-910.PubMed
14.
go back to reference Al Suwaidi J, Higano ST, Holmes R Jr, Lennon R, Lerman A: Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 2001, 37: 1523-1528. 10.1016/S0735-1097(01)01212-8PubMed Al Suwaidi J, Higano ST, Holmes R Jr, Lennon R, Lerman A: Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 2001, 37: 1523-1528. 10.1016/S0735-1097(01)01212-8PubMed
15.
go back to reference Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986, 315: 1046-1051.PubMed Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986, 315: 1046-1051.PubMed
16.
go back to reference Zeiher AM, Drexler H, Wollschlager H, Just H: Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991, 83: 391-401.PubMed Zeiher AM, Drexler H, Wollschlager H, Just H: Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991, 83: 391-401.PubMed
17.
go back to reference Vita JA, Yeung AC, Winniford M, Hodgson JM, Treasure CB, Klein JL, Werns S, Kern M, Plotkin D, Shih WJ, Mitchel Y, Ganz P: Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease. Circulation 2000, 102: 846-851.PubMed Vita JA, Yeung AC, Winniford M, Hodgson JM, Treasure CB, Klein JL, Werns S, Kern M, Plotkin D, Shih WJ, Mitchel Y, Ganz P: Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease. Circulation 2000, 102: 846-851.PubMed
18.
go back to reference Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Luscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine CJ, Pitt B: Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996, 94: 258-265.PubMed Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Luscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine CJ, Pitt B: Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996, 94: 258-265.PubMed
19.
go back to reference Reiber JH, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ, Schuurbiers JC, den Boer A, Hugenholtz PG: Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985, 71: 280-288.PubMed Reiber JH, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ, Schuurbiers JC, den Boer A, Hugenholtz PG: Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985, 71: 280-288.PubMed
20.
go back to reference Labovitz AJ, Anthonis DM, Cravens TL, Kern MJ: Validation of volumetric flow measurements by means of a Doppler-tipped coronary angioplasty guide wire. Am Heart J 1993, 126: 1456-1461. 10.1016/0002-8703(93)90545-KPubMed Labovitz AJ, Anthonis DM, Cravens TL, Kern MJ: Validation of volumetric flow measurements by means of a Doppler-tipped coronary angioplasty guide wire. Am Heart J 1993, 126: 1456-1461. 10.1016/0002-8703(93)90545-KPubMed
21.
go back to reference Ferrari M, Andreas S, Werner GS, Wicke J, Kreuzer H, Figulla HR: Evaluation of an active coronary perfusion balloon device using Doppler flow wire during PTCA. Cathet Cardiovasc Diagn 1997, 42: 84-89. 10.1002/(SICI)1097-0304(199709)42:1<84::AID-CCD24>3.0.CO;2-LPubMed Ferrari M, Andreas S, Werner GS, Wicke J, Kreuzer H, Figulla HR: Evaluation of an active coronary perfusion balloon device using Doppler flow wire during PTCA. Cathet Cardiovasc Diagn 1997, 42: 84-89. 10.1002/(SICI)1097-0304(199709)42:1<84::AID-CCD24>3.0.CO;2-LPubMed
22.
go back to reference Pasternak RC, Thibault GE, Savoia M, DeSanctis RW, Hutter AM Jr: Chest pain with angiographically insignificant coronary arterial obstruction. Clinical presentation and long-term follow-up. Am J Med 1980, 68: 813-817. 10.1016/0002-9343(80)90199-0PubMed Pasternak RC, Thibault GE, Savoia M, DeSanctis RW, Hutter AM Jr: Chest pain with angiographically insignificant coronary arterial obstruction. Clinical presentation and long-term follow-up. Am J Med 1980, 68: 813-817. 10.1016/0002-9343(80)90199-0PubMed
23.
go back to reference Rutledge T, Reis SE, Olson M, Owens J, Kelsey SF, Pepine CJ, Reichek N, Rogers WJ, Merz CN, Sopko G, Cornell CE, Sharaf B, Matthews KA, Women's Ischemia Syndrome E: History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: the WISE study. J Am Coll Cardiol 2001, 37: 780-785. 10.1016/S0735-1097(00)01163-3PubMed Rutledge T, Reis SE, Olson M, Owens J, Kelsey SF, Pepine CJ, Reichek N, Rogers WJ, Merz CN, Sopko G, Cornell CE, Sharaf B, Matthews KA, Women's Ischemia Syndrome E: History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: the WISE study. J Am Coll Cardiol 2001, 37: 780-785. 10.1016/S0735-1097(00)01163-3PubMed
24.
go back to reference Kern MJ, Deligonul U, Tatineni S, Serota H, Aguirre F, Hilton TC: Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. J Am Coll Cardiol 1991, 18: 718-729.PubMed Kern MJ, Deligonul U, Tatineni S, Serota H, Aguirre F, Hilton TC: Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. J Am Coll Cardiol 1991, 18: 718-729.PubMed
25.
go back to reference Nissen SE, Yock P: Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation 2001, 103: 604-616.PubMed Nissen SE, Yock P: Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation 2001, 103: 604-616.PubMed
26.
go back to reference Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B: Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 1989, 79: 287-291.PubMed Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B: Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 1989, 79: 287-291.PubMed
27.
go back to reference Al Suwaidi J, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A: Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000, 101: 948-954. Al Suwaidi J, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A: Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000, 101: 948-954.
28.
go back to reference Chandra HR, Choudhary N, O'Neill C, Boura J, Timmis GC, O'Neill WW: Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS). Am J Cardiol 2001, 88: 214-218. 10.1016/S0002-9149(01)01628-9PubMed Chandra HR, Choudhary N, O'Neill C, Boura J, Timmis GC, O'Neill WW: Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS). Am J Cardiol 2001, 88: 214-218. 10.1016/S0002-9149(01)01628-9PubMed
29.
go back to reference Tanaka T, Matsushita M, Oka Y, Sada T, Kira Y: Effect of Chlamydia pneumoniae infection on coronary flow reserve and intimal hyperplasia after stent implantation in patients with angina pectoris. J Cardiol 2001, 38: 311-317.PubMed Tanaka T, Matsushita M, Oka Y, Sada T, Kira Y: Effect of Chlamydia pneumoniae infection on coronary flow reserve and intimal hyperplasia after stent implantation in patients with angina pectoris. J Cardiol 2001, 38: 311-317.PubMed
30.
go back to reference Kaul R, Uphoff J, Wiedeman J, Yadlapalli S, Wenman WM: Detection of Chlamydia pneumoniae DNA in CD3+ lymphocytes from healthy blood donors and patients with coronary artery disease. Circulation 2000, 102: 2341-2346.PubMed Kaul R, Uphoff J, Wiedeman J, Yadlapalli S, Wenman WM: Detection of Chlamydia pneumoniae DNA in CD3+ lymphocytes from healthy blood donors and patients with coronary artery disease. Circulation 2000, 102: 2341-2346.PubMed
31.
go back to reference Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, Saikku P, Tenkanen L, Manninen V, Hovi T, Manttari M: Infections, inflammation, and the risk of coronary heart disease. Circulation 2000, 101: 252-257.PubMed Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, Saikku P, Tenkanen L, Manninen V, Hovi T, Manttari M: Infections, inflammation, and the risk of coronary heart disease. Circulation 2000, 101: 252-257.PubMed
32.
go back to reference Caligiuri G, Paulsson G, Nicoletti A, Maseri A, Hansson GK: Evidence for antigen-driven T-cell response in unstable angina. Circulation 2000, 102: 1114-1119.PubMed Caligiuri G, Paulsson G, Nicoletti A, Maseri A, Hansson GK: Evidence for antigen-driven T-cell response in unstable angina. Circulation 2000, 102: 1114-1119.PubMed
33.
go back to reference Dechend R, Maass M, Gieffers J, Dietz R, Scheidereit C, Leutz A, Gulba DC: Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 1999, 100: 1369-1373.PubMed Dechend R, Maass M, Gieffers J, Dietz R, Scheidereit C, Leutz A, Gulba DC: Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 1999, 100: 1369-1373.PubMed
34.
go back to reference Danesh J: Antibiotics in the prevention of heart attacks. Lancet 2005, 365: 365-367.PubMed Danesh J: Antibiotics in the prevention of heart attacks. Lancet 2005, 365: 365-367.PubMed
35.
go back to reference Muhlestein JB: Antibiotic treatment of atherosclerosis. Curr Opin Lipidol 2003, 14: 605-614. 10.1097/00041433-200312000-00009PubMed Muhlestein JB: Antibiotic treatment of atherosclerosis. Curr Opin Lipidol 2003, 14: 605-614. 10.1097/00041433-200312000-00009PubMed
36.
go back to reference Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E: C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005, 352: 20-28. 10.1056/NEJMoa042378PubMed Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E: C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005, 352: 20-28. 10.1056/NEJMoa042378PubMed
37.
go back to reference Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Wong Y, Bernardes-Silva M, Ward M: Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 2000, 321: 208-213. 10.1136/bmj.321.7255.208PubMedPubMedCentral Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Wong Y, Bernardes-Silva M, Ward M: Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 2000, 321: 208-213. 10.1136/bmj.321.7255.208PubMedPubMedCentral
Metadata
Title
Lack of association between Chlamydia Pneumoniae serology and endothelial dysfunction of coronary arteries
Authors
Markus Ferrari
Gerald S Werner
Barbara M Richartz
Albrecht Oehme
Eberhard Straube
Hans R Figulla
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2005
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-3-12

Other articles of this Issue 1/2005

Cardiovascular Ultrasound 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.